Recent advances on CDK inhibitors: An insight by means of in silico methods
Author:
Publisher
Elsevier BV
Subject
Organic Chemistry,Drug Discovery,Pharmacology,General Medicine
Reference116 articles.
1. Inhibitors of Cyclin-dependent Kinases as Anti-tumor Agents;Smith,2007
2. Roscovitine-derived, dual-specificity inhibitors of cyclin-dependent kinases and casein kinases 1;Oumata;J. Med. Chem.,2008
3. Effect of mimetic CDK9 inhibitors on HIV-1-activated transcription;Van Duyne;J. Mol. Biol.,2013
4. Proliferation of cancer cells despite CDK2 inhibition;Tetsu;Cancer Cell.,2003
5. Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice;Ortega;Nat. Genet.,2003
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Synthesis, structure analysis, Hirshfeld surface studies, molecular docking studies against cyclin-dependent kinases (CDKs) of sulfonamide decorated N6-benzyl aminopurines for cancer treatment;Results in Chemistry;2024-06
2. Expression of cyclin-dependent kinase 9 is positively correlated with the autophagy level in colon cancer;World Journal of Gastrointestinal Oncology;2024-02-15
3. Assessment of iridoids and their similar structures as antineoplastic drugs by in silico approach;Journal of Biomolecular Structure and Dynamics;2024-02-12
4. Insights into the selectivity of a brain-penetrant CDK4/6 vs CDK1/2 inhibitor for glioblastoma used in multiple replica molecular dynamics simulations;Journal of Biomolecular Structure and Dynamics;2023-12-19
5. A comprehensive analysis of the role of molecular docking in the development of anticancer agents against the cell cycle CDK enzyme;BIOCELL;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3